BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 19674320)

  • 1. Predictors of poor outcomes in steroid therapy for immunoglobulin A nephropathy.
    Shimizu A; Takei T; Uchida K; Tsuchiya K; Nitta K
    Nephrology (Carlton); 2009 Aug; 14(5):521-6. PubMed ID: 19674320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function.
    Moriyama T; Honda K; Nitta K; Yumura W; Nihei H
    Clin Exp Nephrol; 2004 Sep; 8(3):237-42. PubMed ID: 15480901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.
    Manno C; Torres DD; Rossini M; Pesce F; Schena FP
    Nephrol Dial Transplant; 2009 Dec; 24(12):3694-701. PubMed ID: 19628647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of corticosteroid therapy on the progression of IgA nephropathy with moderate proteinuria.
    Uzu T; Harada T; Ko M; Yamato M; Takahara K; Yamauchi A
    Clin Exp Nephrol; 2003 Sep; 7(3):210-4. PubMed ID: 14586717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial.
    Lv J; Zhang H; Chen Y; Li G; Jiang L; Singh AK; Wang H
    Am J Kidney Dis; 2009 Jan; 53(1):26-32. PubMed ID: 18930568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
    Draman CR; Kong NC; Gafor AH; Rahman AF; Zainuddin S; Mustaffa WM; Radzi AM; Shamsul AS
    Singapore Med J; 2008 Nov; 49(11):924-9. PubMed ID: 19037561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of steroids and angiotensin receptor blockers for patients with advanced IgA nephropathy and impaired renal function.
    Moriyama T; Amemiya N; Ochi A; Tsuruta Y; Shimizu A; Itabashi M; Takei T; Uchida K; Nitta K
    Am J Nephrol; 2011; 34(3):233-40. PubMed ID: 21778707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Point of no return (PNR)" in progressive IgA nephropathy: significance of blood pressure and proteinuria management up to PNR.
    Komatsu H; Fujimoto S; Sato Y; Hara S; Yamada K; Morita S; Eto T
    J Nephrol; 2005; 18(6):690-5. PubMed ID: 16358226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fractional urinary excretion of IgG is the most powerful predictor of renoprotection by ACE inhibitors in IgA nephropathy.
    Bazzi C; Rizza V; Paparella M; Casellato D; Napodano P; Olivieri G; D'Amico G
    J Nephrol; 2009; 22(3):387-96. PubMed ID: 19557716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applicability of steroid therapy in 275 adult patients with IgA nephropathy determined using a histological scoring system and degree of proteinuria.
    Suzuki S; Joh K
    Clin Exp Nephrol; 2004 Jun; 8(2):109-16. PubMed ID: 15235927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of corticosteroid and warfarin therapy in IgA nephropathy with crescent formation: preliminary trial.
    Kanno Y; Witt M; Okada H; Nemoto H; Sugahara S; Nakamoto H; Suzuki H
    Clin Exp Nephrol; 2003 Mar; 7(1):48-51. PubMed ID: 14586743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors predicting progression of IgA nephropathies.
    Coppo R; D'Amico G
    J Nephrol; 2005; 18(5):503-12. PubMed ID: 16299675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral calcitriol for reduction of proteinuria in patients with IgA nephropathy: a randomized controlled trial.
    Liu LJ; Lv JC; Shi SF; Chen YQ; Zhang H; Wang HY
    Am J Kidney Dis; 2012 Jan; 59(1):67-74. PubMed ID: 22019331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors that determine an incomplete recovery of renal function in macrohematuria-induced acute renal failure of IgA nephropathy.
    Gutiérrez E; González E; Hernández E; Morales E; Martínez MA; Usera G; Praga M
    Clin J Am Soc Nephrol; 2007 Jan; 2(1):51-7. PubMed ID: 17699387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical effectiveness of steroid pulse therapy combined with tonsillectomy in patients with immunoglobulin A nephropathy presenting glomerular haematuria and minimal proteinuria.
    Kawaguchi T; Ieiri N; Yamazaki S; Hayashino Y; Gillespie B; Miyazaki M; Taguma Y; Fukuhara S; Hotta O
    Nephrology (Carlton); 2010 Feb; 15(1):116-23. PubMed ID: 20377779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multivariate analysis of prognostic factors and effect of treatment in patients with IgA nephropathy.
    Komatsu H; Fujimoto S; Hara S; Sato Y; Yamada K; Eto T; Nakao H
    Ren Fail; 2005; 27(1):45-52. PubMed ID: 15717634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinico-pathological features and outcome in adult patients with Henoch-Schönlein purpura nephritis].
    Tsuruta Y; Takei T; Takano M; Sawara Y; Aoki A; Eguchi A; Kojima C; Moriyama T; Itabashi M; Sugiura H; Tsukada M; Ogawa T; Yoshida T; Uchida K; Tsuchiya K; Nitta K
    Nihon Jinzo Gakkai Shi; 2010; 52(1):51-7. PubMed ID: 20166542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticosteroid therapy in IgA nephropathy with nephrotic syndrome: a long-term controlled trial.
    Lai KN; Lai FM; Ho CP; Chan KW
    Clin Nephrol; 1986 Oct; 26(4):174-80. PubMed ID: 3536231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Participation of extracapillary lesions (ECL) in progression of IgA nephropathy.
    Abe T; Kida H; Yoshimura M; Yokoyama H; Koshino Y; Tomosugi N; Hattori N
    Clin Nephrol; 1986 Jan; 25(1):37-41. PubMed ID: 3955907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of obesity on IgA nephropathy: comparative ultrastructural study between obese and non-obese patients.
    Tanaka M; Yamada S; Iwasaki Y; Sugishita T; Yonemoto S; Tsukamoto T; Fukui S; Takasu K; Muso E
    Nephron Clin Pract; 2009; 112(2):c71-8. PubMed ID: 19390205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.